HIK.L
Hikma Pharmaceuticals PLC
LSE
People also watch:SHP.LHLMA.LAHT.LITRK.LINF.L
2,634.0014.00 (0.53%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close2,620.00
Open2,622.00
Bid2,360.00 x 10900
Ask2,647.00 x 20000
52wk Range1,575.00 - 2,652.00
Day's Range2,588.00 - 2,642.00
Volume413,989
Avg Vol (3m)628,873
As of 12:09 PM EDT. Market closed.
  • Capital Cube5 hours ago

    ETF’s with exposure to Hikma Pharmaceuticals Plc : July 29, 2016

    Click here to see latest analysis ETF’s with exposure to Hikma Pharmaceuticals Plc Here are 5 ETF’s with the largest exposure to HIK-GB. Comparing the performance and risk of Hikma Pharmaceuticals Plc with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker […]

  • Hikma Pharmaceuticals Plc : Undervalued relative to peers, but don’t ignore the other factors
    Capital Cube7 days ago

    Hikma Pharmaceuticals Plc : Undervalued relative to peers, but don’t ignore the other factors

    Hikma Pharmaceuticals Plc relative valuation is now UNDERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 72.Our analysis is based on comparing Hikma Pharmaceuticals Plc with the following peers – Dechra Pharmaceuticals PLC, BTG plc, GlaxoSmithKline plc, GW Pharmaceuticals PLC, AstraZeneca PLC, Summit Therapeutics plc, Sinclair Pharma plc and Vectura Group […] (Read more...) The post Hikma Pharmaceuticals Plc : Undervalued relative to peers, but don’t ignore the other factors appeared first on CapitalCube.